Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and treatment, talks about the importance of preexposure anaphylaxis and why he’s hesitant to jump around the Lenacapavir breakthrough bandwagon. This typical protocol assists sen